Omeros Pre-Tax Profit Margin 2010-2025 | OMER
Omeros pre-tax profit margin from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Omeros Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2020-06-30 | $0.07B | $-0.19B | -279.41% |
| 2020-03-31 | $0.08B | $-0.17B | -211.11% |
| 2019-09-30 | $0.10B | $-0.09B | -89.11% |
| 2019-06-30 | $0.08B | $-0.11B | -148.68% |
| 2019-03-31 | $0.05B | $-0.13B | -260.78% |
| 2018-12-31 | $0.03B | $-0.14B | -448.39% |
| 2018-09-30 | $0.02B | $-0.12B | -521.74% |
| 2018-06-30 | $0.04B | $-0.09B | -220.00% |
| 2018-03-31 | $0.06B | $-0.07B | -123.64% |
| 2017-12-31 | $0.07B | $-0.05B | -81.54% |
| 2017-09-30 | $0.06B | $-0.06B | -87.50% |
| 2017-06-30 | $0.05B | $-0.06B | -118.87% |
| 2017-03-31 | $0.05B | $-0.06B | -134.78% |
| 2016-12-31 | $0.04B | $-0.07B | -165.85% |
| 2016-09-30 | $0.04B | $-0.07B | -194.29% |
| 2016-06-30 | $0.03B | $-0.07B | -274.07% |
| 2016-03-31 | $0.02B | $-0.08B | -390.00% |
| 2015-12-31 | $0.01B | $-0.08B | -584.62% |
| 2015-09-30 | $0.01B | $-0.08B | -1283.33% |
| 2015-06-30 | $0.00B | $-0.08B | -2500.00% |
| 2015-03-31 | $0.00B | $-0.08B | 0.00% |
| 2014-12-31 | $0.00B | $-0.07B | 0.00% |
| 2014-09-30 | $0.00B | $-0.06B | 0.00% |
| 2014-06-30 | $0.00B | $-0.05B | 0.00% |
| 2014-03-31 | $0.00B | $-0.05B | 0.00% |
| 2013-12-31 | $0.00B | $-0.04B | -4000.00% |
| 2013-09-30 | $0.00B | $-0.05B | -1533.33% |
| 2013-06-30 | $0.00B | $-0.05B | -1125.00% |
| 2013-03-31 | $0.01B | $-0.04B | -666.67% |
| 2012-12-31 | $0.01B | $-0.04B | -650.00% |
| 2012-09-30 | $0.01B | $-0.04B | -820.00% |
| 2012-06-30 | $0.01B | $-0.04B | -700.00% |
| 2012-03-31 | $0.00B | $-0.03B | -775.00% |
| 2011-12-31 | $0.00B | $-0.03B | -725.00% |
| 2011-09-30 | $0.00B | $-0.03B | -650.00% |
| 2011-06-30 | $0.00B | $-0.03B | -900.00% |
| 2011-03-31 | $0.00B | $-0.03B | -1500.00% |
| 2010-12-31 | $0.00B | $-0.03B | -3000.00% |
| 2010-09-30 | $0.00B | $-0.03B | 0.00% |
| 2010-06-30 | $0.00B | $-0.03B | 0.00% |
| 2010-03-31 | $0.00B | $-0.02B | 0.00% |
| 2009-12-31 | $0.00B | $-0.02B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.245B | $0.000B |
| Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.716B | 26.12 |
| Boston Scientific (BSX) | United States | $157.517B | 37.62 |
| Stryker (SYK) | United States | $152.893B | 31.97 |
| EssilorLuxottica (ESLOY) | France | $140.240B | 0.00 |
| Medtronic (MDT) | Ireland | $118.558B | 16.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.586B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.070B | 25.15 |
| ResMed (RMD) | United States | $40.718B | 30.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.587B | 16.90 |
| Agilent Technologies (A) | United States | $34.042B | 22.19 |
| Koninklijke Philips (PHG) | Netherlands | $26.981B | 17.85 |
| Terumo (TRUMY) | Japan | $25.673B | 33.35 |
| Insulet (PODD) | United States | $20.514B | 80.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.786B | 12.06 |
| Baxter (BAX) | United States | $14.800B | 11.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.840B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.874B | 23.92 |
| Lantheus Holdings (LNTH) | United States | $4.995B | 12.60 |
| Perrigo (PRGO) | Ireland | $3.859B | 9.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.689B | 16.48 |
| Haemonetics (HAE) | United States | $3.629B | 16.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.441B | 28.59 |
| ICU Medical (ICUI) | United States | $3.119B | 23.00 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.64 |
| QuidelOrtho (QDEL) | United States | $1.720B | 11.83 |
| AtriCure (ATRC) | United States | $1.571B | 0.00 |
| Acuren (TIC) | United States | $1.369B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.272B | 28.62 |
| AdaptHealth (AHCO) | United States | $1.259B | 12.78 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Neogen (NEOG) | United States | $1.048B | 16.66 |
| Curaleaf Holdings (CURLF) | Canada | $0.933B | 0.00 |
| InMode (INMD) | Israel | $0.905B | 9.11 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Valneva SE (VALN) | France | $0.660B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.632B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.581B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| CeriBell (CBLL) | United States | $0.533B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.81 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.322B | 11.83 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.308B | 0.00 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 74.00 |
| Biote (BTMD) | United States | $0.249B | 7.00 |
| Viemed Healthcare (VMD) | United States | $0.247B | 20.87 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.15 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.09 |
| Exagen (XGN) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.18 |
| Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Nephros (NEPH) | United States | $0.037B | 49.57 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |